FDA Schedules Public Discussion on Medical Device User Fee Reauthorization

The U.S. Food and Drug Administration is organizing a public meeting to gather input on the proposed reauthorization of the Medical Device User Fee Amendments (MDUFA). This event is a significant regulatory step for the medical device sector. The reauthorization process will shape future oversight and funding mechanisms for medical devices.